help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, D. K.
Right arrow Articles by Chang, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, D. K.
Right arrow Articles by Chang, C.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 9 4043-4054
Copyright © 2003 by The Endocrine Society


ENDOCRINE MECHANISMS OF DISEASE

Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication

Dong Kun Lee and Chawnshang Chang

George Whipple Laboratory for Cancer Research, Departments of Pathology and Urology, and Cancer Center, University of Rochester Medical Center, Rochester, New York 14642

Address all correspondence and requests for reprints to: Dr. Chawnshang Chang, University of Rochester Medical Center, 601 Elmwood Avenue, Box 626, Rochester, New York 14642. E-mail: chang{at}urmc.rochester.edu.

The androgen-androgen receptor (AR) signaling pathway plays a key role in proper development and function of male reproductive organs, such as prostate and epididymis, as well as nonreproductive organs, such as muscle, hair follicles, and brain. Abnormalities in the androgen-AR signaling pathway have been linked to diseases, such as male infertility, Kennedy’s disease, and prostate cancer. Regulation of AR activity can be achieved in several different ways: modulation of AR gene expression, androgen binding to AR, AR nuclear translocation, AR protein stability, and AR trans-activation. This review covers mechanisms implicated in the control of AR protein expression and degradation, and their potential linkage to the androgen-related diseases. A better understanding of such mechanisms may help us to design more effective androgens and antiandrogens to battle androgen-related diseases.

This work was supported by NIH Grants DK-60905 and DK-60948 and the George Whipple Professorship Endowment.

Abbreviations: AF-1, Activation function-1; AR, androgen receptor; ARE, androgen response element; ARKO, androgen receptor knockout; CAT, chloramphenicol transferase; CP-1, poly(C)-binding protein-1; CRE, cAMP response element; DBD, DNA-binding domain; DHT, 5{alpha}-dihydrotestosterone; ER, estrogen receptor; HuR, Hu protein R; LBD, ligand-binding domain; NF-{kappa}B, nuclear factor-{kappa}B; PEST, proline-, glutamate-, serine-, and threonine-rich; PI3K, phosphatidylinositol-3-hydroxy kinase; PR, progesterone receptor; PSA, prostate-specific antigen; PTEN, phosphatase and tensin homolog deleted from chromosome 10; SBMA, spinal bulbar muscular atrophy; SRC-1, steroid receptor coactivator; T, testosterone; UTR, untranslated region; VES, vitamin E succinate.




This article has been cited by other articles:


Home page
Cancer Res.Home page
C.-C. Yang, Y.-C. Wang, S. Wei, L.-F. Lin, C.-S. Chen, C.-C. Lee, C.-C. Lin, and C.-S. Chen
Peroxisome Proliferator-Activated Receptor {gamma}-Independent Suppression of Androgen Receptor Expression by Troglitazone Mechanism and Pharmacologic Exploitation
Cancer Res., April 1, 2007; 67(7): 3229 - 3238.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
Y. Lin, G. Liu, Y. Zhang, Y.-P. Hu, K. Yu, C. Lin, K. McKeehan, J. W. Xuan, D. M. Ornitz, M. M. Shen, et al.
Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasis
Development, February 15, 2007; 134(4): 723 - 734.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. P. Pelley, K. Chinnakannu, S. Murthy, F. M. Strickland, M. Menon, Q. P. Dou, E. R. Barrack, and G. P.-V. Reddy
Calmodulin-Androgen Receptor (AR) Interaction: Calcium-Dependent, Calpain-Mediated Breakdown of AR in LNCaP Prostate Cancer Cells
Cancer Res., December 15, 2006; 66(24): 11754 - 11762.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. van de Wijngaart, M. E. van Royen, R. Hersmus, A. C. W. Pike, A. B. Houtsmuller, G. Jenster, J. Trapman, and H. J. Dubbink
Novel FXXFF and FXXMF Motifs in Androgen Receptor Cofactors Mediate High Affinity and Specific Interactions with the Ligand-binding Domain
J. Biol. Chem., July 14, 2006; 281(28): 19407 - 19416.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Sugimoto, A. Fujikawa, J. E. Womack, and Y. Sugimoto
Evidence that bovine forebrain embryonic zinc finger-like gene influences immune response associated with mastitis resistance
PNAS, April 25, 2006; 103(17): 6454 - 6459.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Vottero, M. Capelletti, S. Giuliodori, I. Viani, M. Ziveri, T. M. Neri, S. Bernasconi, and L. Ghizzoni
Decreased Androgen Receptor Gene Methylation in Premature Pubarche: A Novel Pathogenetic Mechanism?
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 968 - 972.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Zhoul, G. Hernandez, S.-W. Tu, C.-L. Huang, C.-P. Tseng, and J.-T. Hsieh
The Role of DOC-2/DAB2 in Modulating Androgen Receptor-Mediated Cell Growth via the Nongenomic c-Src-Mediated Pathway in Normal Prostatic Epithelium and Cancer
Cancer Res., November 1, 2005; 65(21): 9906 - 9913.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Yang, S. Xie, Md. S. Jamaluddin, S. Altuwaijri, J. Ni, E. Kim, Y.-T. Chen, Y.-C. Hu, L. Wang, K.-H. Chuang, et al.
Induction of Androgen Receptor Expression by Phosphatidylinositol 3-Kinase/Akt Downstream Substrate, FOXO3a, and Their Roles in Apoptosis of LNCaP Prostate Cancer Cells
J. Biol. Chem., September 30, 2005; 280(39): 33558 - 33565.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Sinha-Hikim, W. E. Taylor, N. F. Gonzalez-Cadavid, W. Zheng, and S. Bhasin
Androgen Receptor in Human Skeletal Muscle and Cultured Muscle Satellite Cells: Up-Regulation by Androgen Treatment
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5245 - 5255.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H.-K. Lin, Y.-C. Hu, D. K. Lee, and C. Chang
Regulation of Androgen Receptor Signaling by PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10) Tumor Suppressor through Distinct Mechanisms in Prostate Cancer Cells
Mol. Endocrinol., October 1, 2004; 18(10): 2409 - 2423.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society